Cancer is a complex disease that is the world's second biggest cause of mortality. Numerous studies in recent years have underlined the dual significance of the gut microbiota in sustaining the health of the host. The term "gut microbiota" refers to the diverse population of commensal microorganisms, mainly bacteria but also fungi, archaea, and viruses that populate the intestinal tract, particularly the large intestine, and it can be thought of as one factor to which we are constantly exposed, at high doses, throughout our lives. The gastro-intestinal resident bacteria and the human body interact at a sophisticated level in the gut. Gut bacteria can produce a variety of metabolites and bioproducts that help to maintain homeostasis in both the host and the gut.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India